Development of an Inclusive Risk Prognostic Index for Newly Diagnosed Multiple Myeloma

P-119: Evaluation of real-world frontline treatment for multiple myeloma by race

COTA expands clinicogenomics offering with Genomic Testing Cooperative partnership.